RNF113A promotes cell survival in lung cancer cells treated with the chemotherapeutic drug Cisplatin by promoting the splicing of prosurvival candidate genes SAT1 and NUPR1. RNF113A also stabilizes the prosurvival protein MCL1 by an unknown mechanism, putatively through a spliceosome-independent manner. Here, RNF113A is linked to lung cancer.